MCL1 and metastatic melanoma: Each of the primary and metastatic melanoma cell lines used in our study showed unique anti-apoptotic protein (e.g., BCL2, BCL-xL and/or MCL-1) expression signature that related with their response to BH3-mimetics (Supplementary Fig. S5A).